Singapore's Veredus Labs Gains CE-IVD Mark for Flu Test, Preps Foodborne Panel for Launch | GenomeWeb

By Justin Petrone

Singaporean molecular diagnostics firm Veredus Laboratories has achieved a CE-IVD mark for its PCR and microarray-based VereFlu test and accompanying VereID Biosystem technology platform, according to a company official.

The firm will also debut next quarter VereFoodborne, a new assay for use in food testing that also runs on the VereID platform, which is manufactured by ST Microelectronics. VereFoodborne is one in a pipeline of new tests the company plans to introduce this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.